Wellington Management Group
AVIR icon

Wellington Management Group’s Atea Pharmaceuticals AVIR Stock Holding History

Wellington Management Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$962K Buy
206,785
+149,776
+263% +$745K ﹤0.01% 1752
2026
Q1 		$307K Sell
57,009
-185,831
-77% -$853K ﹤0.01% 1813
2025
Q4 		$867K Sell
242,840
-19,935
-8% -$63.3K ﹤0.01% 1736
2025
Q3 		$762K Sell
262,775
-96,676
-27% -$330K ﹤0.01% 1826
2025
Q2 		$1.29M Buy
359,451
+54,921
+18% +$164K ﹤0.01% 1677
2025
Q1 		$911K Buy
304,530
+86,021
+39% +$268K ﹤0.01% 1722
2024
Q4 		$732K Sell
218,509
-3,053
-1% -$10.1K ﹤0.01% 1779
2024
Q3 		$742K Sell
221,562
-33,604
-13% -$122K ﹤0.01% 1763
2024
Q2 		$845K Sell
255,166
-94,838
-27% -$354K ﹤0.01% 1710
2024
Q1 		$1.41M Buy
+350,004
New +$1.37M ﹤0.01% 1603
2023
Q2 		– Sell
-286,233
Closed -$959K – 1816
2023
Q1 		$959K Sell
286,233
-11,507
-4% -$46.7K ﹤0.01% 1669
2022
Q4 		$1.43M Buy
297,740
+69,775
+31% +$353K ﹤0.01% 1574
2022
Q3 		$1.3M Buy
227,965
+139,754
+158% +$1.07M ﹤0.01% 1609
2022
Q2 		$626K Sell
88,211
-130
-0.1% -$887 ﹤0.01% 1771
2022
Q1 		$637K Buy
88,341
+17,235
+24% +$117K ﹤0.01% 1830
2021
Q4 		$635K Buy
71,106
+50,716
+249% +$790K ﹤0.01% 1896
2021
Q3 		$715K Sell
20,390
-468,955
-96% -$13M ﹤0.01% 1845
2021
Q2 		$10.5M Buy
489,345
+446,979
+1,055% +$13.4M ﹤0.01% 1256
2021
Q1 		$2.62M Sell
42,366
-349
-0.8% -$23.6K ﹤0.01% 1570
2020
Q4 		$1.78M Buy
+42,715
New +$1.38M ﹤0.01% 1509

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wellington Management Group's AVIR Position: Q2 2026 in Review

Wellington Management Group increased its Atea Pharmaceuticals (AVIR) stake by 263% in Q2 2026, buying an estimated $745K and bringing the position to 206,785 shares worth $962K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

Wellington Management Group first reported a position in AVIR in Q4 2020 and has held it in 20 quarters since. The position peaked at $10.5M in Q2 2021. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Wellington Management Group held 206,785 shares of Atea Pharmaceuticals worth $962K as of Q2 2026.
  • Wellington Management Group bought 149,776 Atea Pharmaceuticals shares in Q2 2026, an estimated $745K.
  • Atea Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1752 holding.
  • Wellington Management Group first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • Wellington Management Group's Atea Pharmaceuticals position peaked at $10.5M in Q2 2021.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.